drugset / Trial / NCT01949675

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

NCT01949675

Phase 4 Completed 336 enrolled Sanofi Pasteur, a Sanofi Company
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim of the study is to generate safety and immunogenicity data with Oral Cholera Vaccine (Shanchol™) in The Philippines Objectives: * To describe the safety after each dose of Shanchol vaccine. * To describe the immunogenicity after each dose of Shanchol vaccine.

Timeline

Start
2014-03
Primary completion
2015-02
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Shanchol Vaccine 1.5 ml Oral

Indications